如何管理注射用培美曲塞二钠相关皮疹? |
本文旨在提供关于注射用培美曲塞二钠皮疹的相关信息,仅供医疗卫生专业人士参考。 |
回复:
参考文献
1Rusthoven JJ, Eisenhauer E, Butts C, et al; National Cancer Institute of Canada Clinical Trials Group. Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non–small-cell lung cancer: a phase II study. J Clin Oncol. 1999;17(4):1194-1199. http://dx.doi.org/10.1200/jco.1999.17.4.1194
2Thödtmann R, Depenbrock H, Dumez H, et al. Clinical and pharmacokinetic phase I study of multitargeted antifolate (LY231514) in combination with cisplatin. J Clin Oncol. 1999;17(10):3009-3016. http://dx.doi.org/10.1200/JCO.1999.17.10.3009
3Clarke SJ, Abratt R, Goedhals L, et al. Phase II trial of pemetrexed disodium (ALIMTA®, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer. Ann Oncol. 2002;13(5):737-741. http://dx.doi.org/10.1093/annonc/mdf115
4Data on file, Eli Lilly and Company and/or one of its subsidiaries.
5Tummino C, Barlesi F, Tchouhadjian C, et al. Severe cutaneous toxicity after pemetrexed in second line treatment for a refractory non small cell lung cancer [French]. Rev Mal Respir. 2007;24(5):635-638. https://doi.org/10.1016/S0761-8425(07)91133-X
6Bosch-Barrera J, Gaztañaga M, Ceballos J, et al. Toxic epidermal necrolysis related to pemetrexed and carboplatin with vitamin B12 and folic acid supplementation for advanced non-small cell lung cancer. Onkologie. 2009;32(10):580-584. https://doi.org/10.1159/000232315
7Scheinpflug K, Menzel C, Koch A, et al. Toxic epidermal necrolysis related to cisplatin and pemetrexed for metastatic non-small cell lung cancer. Onkologie. 2012;35(10):600-603. https://doi.org/10.1159/000342671
8Then C, von Einem JC, Müller D, et al. Toxic epidermal necrolysis after pemetrexed and cisplatin for non-small cell lung cancer in a patient with Sharp syndrome. Onkologie. 2012;35(12):783-786. https://doi.org/10.1159/000345109
9Huang JJ, Ma SX, Hou X, et al. Toxic epidermal necrolysis related to AP (pemetrexed plus cisplatin) and gefitinib combination therapy in a patient with metastatic non-small cell lung cancer. Chin J Cancer. 2015;34(2):94-98. https://doi.org/10.5732/cjc.014.10151
10Aksoy B, Cavusoglu EU. Toxic epidermal necrolysis like antifolate cytotoxic skin reaction due to pemetrexed [Turkish]. Turk J Dermatol. 2018;12(1):68-70. https://doi.org/10.4274/tdd.3066
11Declercq I, Lievens Y, Verbeken E, Vansteenkiste J. Rash in a patient treated with pemetrexed for relapsed non-small cell lung cancer. J Thorac Oncol. 2008;3(6):662-663. https://doi.org/10.1097/JTO.0b013e318170fcb9
12Eichhoff G. Slowly developing toxic epidermal necrolysis-like reaction associated with pemetrexed and carboplatin. Ecancermedicalscience. 2020;14:1010. https://doi.org/10.3332/ecancer.2020.1010
13David E, Krishna R, Ramachandran L, et al. Pemetrexed-associated hyperpigemented skin rash. Am J Ther. Published online February 06, 2020. https://doi.org/10.1097/mjt.0000000000001146
14Chow KVC, O'Leary C, Paxton-Hall F, et al. Pembrolizumab-induced toxic epidermal necrolysis: case report. Oxf Med Case Rep. 2022;2022(3):112-114. https://dx.doi.org/10.1093/omcr/omac025